Pantheon Industries
 | |
| Private | |
| Industry |
|
| Founded | 1920 |
| Founder | Georgis Kattapoulos |
| Headquarters | |
Area served | Worldwide |
Key people | Oiksi Iivostner (Chairman) |
Number of employees | 85,150 |
Pantheon Industries is a multinational conglomerate based in Caphiria. It acts as the main holding company for a number of subsidiaries, offering products in the chemical, life-sciences, materials science, pharmaceuticals, and energy sector. Pantheon has 85,150 employees worldwide with annual revenues of $27 billion.
Pantheon Industries traces its origin to the late 19th century as the Katta Fishing Corp., which had gained immense value after gaining a monopoly on the global tuna market by exploiting fishing zones in the Sea of Canete. Its owner, Georgis Kattapoulos, had a "spiritual awakening" in 1899 which led to his self-publishing of "Society at the Dawn of the 20th Century" in 1901, after which he began to spend most of his wealth building, buying, or investing in businesses which he deemed visionary or "seminal for society". In 1920, Kattapoulos restructured the company by renaming it Katta Seafood and formed a separate company called Pantheon Industries for his alternative business interests. Pantheon Industries would focus on the development of drugs for the treatment of infectious diseases and is responsible for the discovery of the antibacterial effects of penicillin.
Pantheon Industries would go on to spend most of the 20th century as a leader in the pharmaceutical industry, pioneering the commercial manufacture of morphine and for a time held a monopoly on cocaine production, as well as manufacturing war essential products such as narcotics, vitamins, biocides and other chemicals.
Today, Pantheon Industries has diversified its portfolio and is still dominant in the pharmaceutical, chemical, and bio-science sectors. It is one of the world's oldest operating chemical and pharmaceutical companies, as well as one of the largest pharmaceutical companies in the world. The current chairman of Pantheon Industries is Oiksi Iivostner, who was appointed in 2021 after the ousting of the former chairman Bob Dole.
Businesses and investments
Subsidiaries
- Pharmonis - Founded in 1922, Pharmonis is a pharmaceutical company that mainly operates in the acquisition (for repricing), manufacturing, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients (APIs). In 1983, after concerns about tax evasion and an eventual inquiry from The Imperium, Pharmonis suffered its biggest one-day share price fall in its history. The loss equated equated to half of its market value, at which point Pantheon acquired Pharmonis. Today, the company operates in three segments; Consumer Healthcare, Rx Pharmaceuticals, and Active Pharmaceutical Ingredients.
- Lyonardo - Founded in 1978, Lyonardo is a multinational biotechnology company based in Hekhov, Diamavya specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide. Lyonardo owns the rights to Fumaderm and BG-12, an oral fumarate, which is being studied for the treatment of multiple sclerosis and psoriasis.It also owns the patent for a treatment for hemophilia B as well as the technology for developing inhalable treatments. Lyonardo is known for acquiring smaller biotech companies and poaching prominent biologists and has come under scrutiny for these aggressive tactics. It was acquired by Pantheon in 1993 for $3.25 billion.
- Tyran Oil and Hydrocarbons - founded in 1959 as Tyran Coal during the coal-boom in southern Caphiria and was the largest mining company originating in the Imperium. Acquired in 2001 for an undisclosed sum.
- Vitra Labs - acquired by Pantheon in 2020 for $400 million
- Reidius Science - acquired by Pantheon in 2006 for $30 million
- Cyntexia Technologies - acquired by Pantheon in 1997 for $17.4 million
- Adastrus Pharmaceutical - acquired by Pantheon in 2022 for $13.1 billion
- Electreus Energy - acquired by Pantheon in 2023 for $1.4 billion
- Helixa Life - acquired by Pantheon in 2027 for $240 million
- Quadreum Nuclear - acquired by Pantheon in 2029 for $62.4 billion; the largest acquisition to date by Pantheon
- Dentota - acquired by Pantheon in 2033 for $150 million
- Atmios - acquired by Pantheon in 2034 for $11 million
Investments
- Pantheon Industries owns 43.4% of Elanus, a highly specialized defense and IT systems manufacturer. Elanus is known for its specialized tracking and data processing units which can be found in anything from security cameras to satellites. It focuses on producing highly specialized products with military applications.
- It maintains a sizeable non-controlling interest in Agroleum Comitat, Compor Mining, Baiereal Petrochemical, and the Marín-Helius Corporation
- Pantheon owns an 8.9% stake in Ilyas, a global sensory company that specializes on radars, sonars, and IR systems for civil and military applications
- Pantheon also maintains a 1.4% investment in Quicksilver Industries
- Pantheon acquired a 5% stake in The Hansa Group